United States & Roche
19 shared events · Importance 4 · Last updated Aug 24, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
United States: The United States is experiencing a cyclospora outbreak, which the new tests aim to address, but the outbreak itself has negative public health implications.
Roche: Roche is the main actor, launching new PCR tests to expand its cyclospora portfolio, reinforcing its position in infectious disease diagnostics and potentially boosting sales.
Aug 06, 2026 · 6 articles
International
United States: The United States is receiving significant investment from Swiss companies, which will boost its economy and create jobs, though it also imposed new tariffs related to forced labor.
Roche: Roche is expanding its output in North Carolina as part of the Swiss investment surge.
Jun 07, 2026 · 7 articles
Tech
United States: The United States is a key country within North American Cobalt Inc., contributing to the region's dominance in the epigenetics market through its strong research infrastructure and leading companies.
Roche: Roche Ltd. is recognized as a top company in the epigenetics market, indicating its significant role and potential to benefit from market expansion.
Jun 26, 2026 · 6 articles
Business
United States: The US is part of North America, which held the largest market share in 2025, supported by strong regulatory frameworks and advanced manufacturing.
Roche: Roche is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Business
United States: Major market and home to several key players.
Roche: Major diagnostics provider; growth forecasts favorable.
Jul 08, 2026 · 6 articles
Accidents
United States: United States>>> has bolstered precautions, including screening air passengers and suspending visa services, and has provided $13 million in assistance for the response.
Roche: Roche is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Business
United States: The U.S. benefits from increased domestic manufacturing capacity and supply chain resilience, aligning with broader efforts to boost domestic production.
Roche: Roche, as parent company, is investing in the facility as part of its $50 billion U.S. commitment, enhancing its manufacturing network and long-term growth prospects.
Aug 18, 2026 · 6 articles
Domestic
United States: The United States economy faces uncertainty due to new tariffs, with potential for higher inflation, dampened hiring, and increased costs for consumers and businesses.
Roche: Roche, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Business
United States: The United States is the region where Roche and Nurix Therapeutics, Inc. will equally split profits and losses from the commercialization of bexobrutideg.
Roche: Roche has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics to co-develop and co-commercialize bexobrutideg, strengthening its hematology portfolio and expanding into immunology and neurology. This deal positions Roche to potentially lead in the BTK degrader market.
Jun 07, 2026 · 22 articles
Tech
United States: The oral presentation will explore new data evaluating Eversense 365 performance and impact in open and closed loop systems in the United States.
Roche: As the parent company of F. Hoffmann-La Roche — Genentech, Roche benefits from the positive clinical trial results of enicepatide and petrelintide, which enhance its overall pharmaceutical pipeline and potential for future revenue in the obesity and diabetes markets.
May 27, 2026 · 19 articles
Tech
United States: The United States>>> is the country where the United States — Food and Drug Administration>>> operates and where the New Drug Application for giredestrant was accepted.
Roche: As the parent company of F. Hoffmann-La Roche — Genentech>>>, Roche>>> benefits from the positive developments regarding giredestrant's regulatory progress and its potential market impact.
Jun 02, 2026 · 6 articles
Business
United States: The United States' stance on potential attacks against Iran and its inventory drawdown affected oil prices. United States — Federal Reserve minutes also indicated concerns about inflation and potential interest rate hikes.
Roche: Roche agreed to pay Nurix Therapeutics up to $2.3 billion for rights to an experimental blood-cancer drug.
May 20, 2026 · 72 articles
Tech
United States: The US is the primary market for the treatment, with regulatory approval and healthcare system implications.
Roche: Roche is testing a similar personalized cancer vaccine, and the positive results could boost its own development efforts.
Aug 19, 2026 · 108 articles
Business
United States: The U.S. is a key market where Alvogen and Lotus will commercialize the biosimilars, with Alvogen retaining direct commercialization rights.
Roche: Roche's Hemlibra faces potential biosimilar competition, which could affect its sales, though the impact is long-term and uncertain.
Aug 21, 2026 · 6 articles
Business
United States: Dominant market with advanced healthcare infrastructure and AI adoption.
Roche: Partnered with PathAI for AI-enabled companion diagnostics; key player in digital pathology.
Jun 24, 2026 · 8 articles
Domestic
United States: Prospects of a peace deal between Iran>>> and the United States>>> influenced investor sentiment, contributing to the positive mood in the Switzerland>>> market.
Roche: Roche>>> posted modest gains, contributing to the overall positive sentiment in the Switzerland>>> market.
May 21, 2026 · 8 articles
Business
United States: The U.S. is a key market where Teva will commercialize the biosimilar upon approval.
Roche: Roche's Ocrevus franchise may face competition from the biosimilar, potentially impacting revenues.
Jul 09, 2026 · 14 articles
International
Roche: Roche's vice chair, André Hoffmann, is a co-chair of the World Economic Forum annual meeting.
Jan 19, 2026 · 6 articles
70
Roche invested $50 billion United StatesGenentech tops out Holly...
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and Roche interact across events, view sentiment trends, and discover connected entities.
Open Dashboard